Cargando…

A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients

Roxadustat (Rox), a hypoxia-inducible factor (HIF) stabilizer, is now available for the treatment of anemia in hemodialysis (HD) patients. To investigate hematopoietic effect and iron metabolism, this study involved 30 HD patients who were initially treated with darbepoetin (DA), a conventional eryt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogawa, Chie, Tsuchiya, Ken, Tomosugi, Naohisa, Maeda, Kunimi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583824/ https://www.ncbi.nlm.nih.gov/pubmed/32998272 http://dx.doi.org/10.3390/ijms21197153

Ejemplares similares

Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa
por: Ogawa, Chie, et al.
Publicado: (2021)

Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study
por: Ogawa, Chie, et al.
Publicado: (2017)

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
por: Ogawa, Chie, et al.
Publicado: (2023)

Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational Study
por: Ogawa, Chie, et al.
Publicado: (2022)

High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study
por: Ogawa, Chie, et al.
Publicado: (2020)

Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis
por: Yoshida, Shunsuke, et al.
Publicado: (2023)

Tips for erythropoiesis-stimulating agent treatment of renal anemia
por: Tomosugi, Naohisa, et al.
Publicado: (2019)

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2016)

Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients
por: Takasawa, Kazuya, et al.
Publicado: (2014)

Administration of pentoxifylline to improve anemia of hemodialysis patients
por: Shahbazian, Heshmatolah, et al.
Publicado: (2016)

Oral Iron Absorption of Ferric Citrate Hydrate and Hepcidin-25 in Hemodialysis Patients: A Prospective, Multicenter, Observational Riona-Oral Iron Absorption Trial
por: Tomosugi, Naohisa, et al.
Publicado: (2023)

Vitamin C and functional iron deficiency anemia in hemodialysis()
por: Kim, Yong-Lim
Publicado: (2012)

Rb and hematopoiesis: stem cells to anemia
por: Walkley, Carl R, et al.
Publicado: (2008)

Recent advances in understanding hematopoiesis in Fanconi Anemia
por: Bagby, Grover
Publicado: (2018)

Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2020)

Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis
por: Wielockx, Ben, et al.
Publicado: (2019)

Posterior mediastinal extramedullary hematopoiesis secondary to hypoxia
por: Solazzo, A, et al.
Publicado: (2016)

APC/C is essential for hematopoiesis and impaired in aplastic anemia
por: Wang, Jia, et al.
Publicado: (2017)

Influence of proton pump inhibitors and histamine H(2) receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review
por: Tatsuzawa, Masaomi, et al.
Publicado: (2016)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012)

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
por: Macdougall, Iain C., et al.
Publicado: (2019)

Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy
por: Rognoni, Carla, et al.
Publicado: (2019)

IRON METABOLISM IN EXPERIMENTAL ANEMIA : "AVAILABILITY OF IRON"
por: Hahn, P. F., et al.
Publicado: (1938)

The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment
por: Alvarez-Martins, Inês, et al.
Publicado: (2016)

Integration of gut microbiota and metabolomics for the hematopoiesis of Siwu paste on anemia rats
por: Wan, Dan, et al.
Publicado: (2023)

Chapter 2: Use of iron to treat anemia in CKD
Publicado: (2012)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Long-term administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism
por: KITADE, HIRONORI, et al.
Publicado: (2014)

A Retrospective Study of Various Iron Preparations Oral Administration in Pregnant Women with Iron Deficiency Anemia
por: Constantinos, Bouschanetzis, et al.
Publicado: (2023)

Thoracic and paraspinal extramedullary hematopoiesis in a cat with chronic non-regenerative anemia
por: Bolfa, Pompei, et al.
Publicado: (2018)

Adrenal extramedullary hematopoiesis in the setting of anti-Diego antibody and congenital dyserythropoietic anemia
por: Julson, Janet Rae, et al.
Publicado: (2022)

Iron deficiency anemia and glucose metabolism
por: T Soliman, Ashraf, et al.
Publicado: (2017)

Iron-heme-Bach1 axis is involved in erythroblast adaptation to iron deficiency
por: Kobayashi, Masahiro, et al.
Publicado: (2017)

Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects
por: Flamme, Ingo, et al.
Publicado: (2014)

Iron-Hepcidin Dysmetabolism, Anemia and Renal Hypoxia, Inflammation and Fibrosis in the Remnant Kidney Rat Model
por: Garrido, Patrícia, et al.
Publicado: (2015)

Tetramethylpyrazine nitrone activates hypoxia-inducible factor and regulates iron homeostasis to improve renal anemia
por: Cen, Yun, et al.
Publicado: (2022)

Hemodialysis patients’ preferences for the management of anemia
por: Hauber, Brett, et al.
Publicado: (2017)

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk
por: Ganz, Tomas, et al.
Publicado: (2020)

Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma
por: Kamai, Takao, et al.
Publicado: (2009)

The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease
por: Zhong, Hongzhen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qc62p58o1chlac5nsmj75hne2u